About MacroGenicsPipelineTechnologyBusiness DevelopmentNewsEmploymentContact
MacroGenics Home
 

 

MacroGenics, Inc. is developing immunotherapeutics, including monoclonal antibodies, to treat patients with cancer, autoimmune disorders, allergy, or infectious diseases.


Pipeline Highlight

Technology Highlights

   Anti-CD3 (teplizumab)

arrowbullet Anti-CD32B

arrowbullet Anti-CD16

arrowbullet Capabilities

Click here for more information on our Protégé Trial.
 
© 2008 MacroGenics. All Rights Reserved. Home | Site Map | Privacy Policy
MacroGenics Inc. | 1500 East Gude Drive | Rockville, MD 20850
P. 301.251.5172 | F. 301.251.5321 | E. HResources@macrogenics.com(hiring); info@macrogenics.com (business);